Latest news with #RespiratoryDisease
Yahoo
15-05-2025
- Health
- Yahoo
COVID on the Climb: Health Officials Urge Caution, Not Panic
It's something many of us had hoped we'd left behind. But COVID-19 is making a quiet comeback across the islands. The state is reporting a noticeable increase in new cases this week, along with the flu. But as health officials tells us, this isn't cause for panic, but it is reason to stay informed. It may not be making the headlines like it used to but COVID-19 is still with us – and this week, it's making a bit more noise. According to the State Department of Health, 210 new COVID-19 cases have been reported in Hawaii this week. 'I would say compared to past years, it's still a very modest increase that we're seeing this time of year, but we have seen summer surges in Hawaii. So I think it's something to pay attention to,' said Dr. Sarah Kemble, State Epidemiologist. Our senior population is seeing the greatest increase in COVID cases – an average of 23 new cases reported this week. The variant circulating is the LP variant. 'It's something that's been seeing emerging globally. It does seem to have an advantage over other variants, but it's not associated with more severe disease or greater resistance to vaccine,' said Dr. Kemble. Other respiratory illnesses. like the flu, are also seeing a slight rise, accounting for 11% of positive tests and 2% of emergency room visits. Not as high as the peak of flu season when it's closer to a 305 positive rate, but there has been increased activity, particularly in children. 'Technically we're out of the flu season, but we're still seeing cases every day. I'm still seeing a fairly good number of COVID cases as well. I would say the RSV cases are probably the least of those three, but I'm seeing a case here and there,' said Dr. Paul Eakin, JABSOM Pediatric Emergency Medicine Division Chief. The health department's overall disease activity indicator is currently at a medium level. Dr. Eakin says the latest wave isn't unexpected considering that respiratory illnesses occur year round in Hawaii. 'Because we get tourists from the mainland. We also get tourists from the southern hemisphere. So I don't know if flu ever truly goes away. And then I think COVID is also kind of here to stay,' said Dr. Eakin. So what should you do if you're feeling sick right now? The advice is simple – but important. 'I think the biggest take home point is if you're feeling sick, if you're having sore throat, runny nose, cough, and especially if you're having fever, safest thing is to stay home and not spread your germs until you're feeling better,' said Dr. Kemble. Doctors also recommend staying up to date on vaccines. A link to the State Health Department's Respiratory Disease Dashboard is here: Respiratory Viruses Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
06-02-2025
- Health
- Yahoo
Respiratory Disease Vaccines Market Research Report 2025: Analysis and Forecast (2020-2030) Featuring GSK, Johnson & Johnson Services, Pfizer, Sanofi, Serum Institute of India, SINOVAC Biotech & More
Analyze Global, Regional, and Country-Level Growth Trends by Type, Infection, and Distribution Channel Respiratory Disease Vaccine Market Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to Respiratory Disease Vaccine Market was valued at USD 94.60 billion in 2024, and is expected to reach USD 101.56 billion by 2030, rising at a CAGR of 1.15%. The global aging population is at a higher risk of respiratory diseases. As the elderly population grows, there is a greater need for vaccines to protect this vulnerable group. Government and healthcare organizations worldwide recommend or mandate vaccinations for certain respiratory diseases, such as influenza. These recommendations drive vaccine adoption and coverage rates. The emergence of new respiratory viruses, as witnessed during the COVID-19 pandemic, highlights the importance of preparedness through and organizations invest in vaccines as a key part of pandemic response plans. Public health campaigns and initiatives promote vaccination and raise awareness about the benefits of respiratory disease vaccines. These efforts aim to increase vaccine uptake. International organizations like the World Health Organization (WHO) and UNICEF work to expand vaccination access in low- and middle-income countries. Global immunization programs aim to reduce the burden of respiratory Market Drivers Increasing Prevalence of Respiratory Diseases Rising Aging Population Vaccine Mandates and Recommendations Global Immunization Programs Key Market Challenges Vaccine Hesitancy and Misinformation Supply Chain Disruptions Key Market Trends Pneumococcal Vaccines Asia Pacific held the largest market share in the Global Respiratory Disease Vaccine Market in 2024. The Asia Pacific region is home to a substantial portion of the world's population, including densely populated countries like China and India. The sheer number of people in the region creates a significant market for respiratory disease vaccines. Many countries in the Asia Pacific have been experiencing economic growth, leading to increased healthcare spending. This has allowed for greater investment in healthcare infrastructure, including vaccination about the importance of vaccination has been on the rise in the Asia Pacific region. Governments and healthcare organizations have been actively promoting immunization, including respiratory disease vaccines, to combat the burden of preventable diseases. Like many other regions, the Asia Pacific is experiencing demographic changes with a growing aging population. Older adults are more susceptible to respiratory diseases, such as influenza and pneumonia, driving the demand for Market Players GSK PLC Johnson & Johnson Services, Inc. Pfizer Inc. Sanofi SA Serum Institute of India Pvt. Ltd. SINOVAC Biotech Ltd. Bavarian Nordic A/S Merck & Co. Inc. AstraZeneca PLC Report ScopeIn this report, the Global Respiratory Disease Vaccine Market has been segmented into the following categories:By Type Viral Vaccine Bacterial Vaccine Combination Vaccine By Infection COVID-19 Influenza Respiratory Syncytial Virus (RSV) Pneumonia Others By Distribution Channel Hospital & Retail Pharmacies Government Suppliers Others By Region North America United States Canada Mexico Asia-Pacific China India South Korea Australia Japan Europe Germany France United Kingdom Spain Italy South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE Key Attributes Report Attribute Details No. of Pages 180 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $94.6 Billion Forecasted Market Value (USD) by 2030 $101.56 Billion Compound Annual Growth Rate 1.1% Regions Covered Global For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Respiratory Disease Vaccine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
